// App-Quantinova.ai

: Late Breaking Abstract - Cluster analysis of treatable traits in the U-BIOPRED adult severe asthma cohort

Researchers

Presenter

  • Andrew Simpson

Principal Investigators

  • Dominick Shaw

  • John Riley

  • Ana Sousa

  • Louise Fleming

  • Graham Roberts

  • Aruna Bansal

  • Scott Wagers

  • Ratko Djukanovic

  • Per Bakke

  • Florian Singer

  • Ildik Horvath

  • Massimo Caruso

  • Norbert Krug

  • Pascal Chanez

  • Jacek Musial

  • Sven-Erik Dahlen

  • Jorgen Vestbo

  • Kian Fan Chung

  • Peter Sterk

  • Stephen Fowler

  • Thomas Sandstrom

  • Paolo Montuschi

Medical Centers

  • Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester and University Hospital of South Manchester, NHS Foundation Trust, Manchester, United Kingdom, Manchester, United Kingdom

  • Pulmonary Medicine, Academic Medical Centre, Amsterdam, Netherlands

  • Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, Notts, United Kingdom

  • Respiratory Therapeutic Unit, GSK, London, United Kingdom

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • NIHR Respiratory Biomedical Research Unit, Southampton, United Kingdom.

  • Acclarogen Ltd, St John’s Innovation Centre, Cambridge, United Kingdom

  • BioSciConsulting, Maasmechelen, Belgium,

  • Institute of Medicine, University of Bergen, Bergen, Norway

  • University Hospital Zurich, Zurich, Switzerland, Zurich, Switzerland

  • Department of Pulmonology, Semmelweis University, Budapest, Hungary

  • Department of Clinical and Experimental Medicine Hospital University, University of Catania, Catania, Italy

  • Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany,

  • Département des Maladies Respiratoires, Laboratoire d’immunologie, Aix Marseille Université Marseille, Marseille, France

  • Department of Biochemistry, Jagiellonian University Medical College, Krakow, Poland

  • Lung/Allergy Clinic, Karolinska University Hospital Huddinge, Stockholm, Sweden

  • National Heart and Lung Institute, Imperial College London & NIHR Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, United Kingdom

  • Dept of Medicine, Dept of Public Health and Clinical Medicine Respiratory Medicine Unit, Umeå University, Umeå, Sweden

  • Faculty of Economics, Catholic University of the Sacred Heart, Rome, Italy

Locations

  • United Kingdom

  • Netherlands

  • Belgium

  • Norway

  • Switzerland

  • Hungary

  • Italy

  • Germany

  • France

  • Poland

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A